investors reatapharma.com
Investor Overview Reata Pharmaceuticals
Investors Reata Pharmaceuticals, Inc. is a private company headquartered in Irving, Texas, focused on delivering novel medicines for difficult-to-treat
OVERVIEW
The site investors.reatapharma.com presently has a traffic classification of zero (the smaller the superior). We have crawled zero pages within the web page investors.reatapharma.com and found forty websites referencing investors.reatapharma.com. We have unearthed two mass network accounts retained by this website.
Links to this site
40Social Links
2INVESTORS.REATAPHARMA.COM TRAFFIC
The site investors.reatapharma.com is seeing alternating amounts of traffic for the duration of the year.
Date Range
1 week
1 month
3 months
This Year
Last Year
All time
Date Range
All time
This Year
Last Year
Date Range
All time
This Year
Last Year
Last Month
LINKS TO INVESTORS.REATAPHARMA.COM
Home Reata Pharmaceuticals
Creating New Opportunities for Patients. Reata is conducting five Phase 2 studies in cardiovascular, ophthalmology, rare diseases, and immuno-oncology. Data expected in 2015 and 2016. A new approach to PAH. Data expected the second half of 2015 and first half of 2016. Working to improve cataract surgery. RTA 408 Post-Surgical CEC Loss.
WHAT DOES INVESTORS.REATAPHARMA.COM LOOK LIKE?
INVESTORS.REATAPHARMA.COM SERVER
We found that the main root page on investors.reatapharma.com took nine hundred and fifty-three milliseconds to stream. Our crawlers could not find a SSL certificate, so therefore our crawlers consider investors.reatapharma.com not secure.
Load time
0.953 sec
SSL
NOT SECURE
IP
23.215.102.19
SITE TITLE
Investor Overview Reata PharmaceuticalsDESCRIPTION
Investors Reata Pharmaceuticals, Inc. is a private company headquartered in Irving, Texas, focused on delivering novel medicines for difficult-to-treatPARSED CONTENT
The site states the following, "Nasdaq RETA is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in regulating cellular metabolism and inflammation." I noticed that the web site stated " Our two most advanced clinical candidates bardoxolone methyl and omaveloxolone target important transcription factors, called Nrf2 and NF-."SEE MORE WEB PAGES
conversations with everyday bigots, like yourself. Just another WordPress.com site
Conversations with everyday bigots, like yourself. EBs are generally supremacists, so you can count on them being nationalistic. Her responses became increasingly problematic, and invited some.
Looking To Be Undone
No really, you are a terrible person.
The Upstate Table - Home
The Upstate Table hosts gatherings that celebrate food, community and local producers.